Biography:
Miss. Zhu is a dual-degree candidate (BSc Clinical Medicine, Nanchang University; BSc Biomedicine, Queen Mary University of London, 2021–2026) with interdisciplinary expertise in clinical practice, bioinformatics, and translational research. Her academic work includes pan-cancer studies on KLF transcription factors, IFN mechanisms in viral-associated cancers, and independent research on CYR61 in liver cancer, resulting in peer-reviewed publications (2022, 2024). Clinically, she trained in diverse departments (oncology, neurosurgery, etc.), refining diagnostic and patient management skills. Currently, she applies epidemiological statistics and GBD database analysis to investigate global disease burdens.
Title : Horizontal comparison of the trend of pancreatic cancer in China and abroad: Lower development correlates with reduced pancreatic cancer burden, defying SDI-based predictions